SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-001330
Filing Date
2021-01-11
Accepted
2021-01-11 09:27:45
Documents
5
Period of Report
2021-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea132847-8k_silopharma.htm 8-K 21007
2 PATENT LICENSE AGREEMENT BY AND AMONG THE COMPANY AND SILO PHARMA, INC., A DELAW ea132847ex10-1_silo.htm EX-10.1 126017
3 PRESS RELEASE, DATED JANUARY 6, 2021 ea132847ex99-1_silo.htm EX-99.1 5915
4 PRESS RELEASE, DATED JANUARY 11, 2021 ea132847ex99-2_silo.htm EX-99.2 8103
5 GRAPHIC ex99-2_001.jpg GRAPHIC 7656
  Complete submission text file 0001213900-21-001330.txt   173209
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54872 | Film No.: 21519554
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl